Peapack-Gladstone Financial (PGC) Reaches $33.59 After 3.00% Up Move, Rexahn Pharmaceuticals (RNN) Has 0.58 Sentiment

July 17, 2017 - By sdlfksdklf klsdf

The stock of Peapack-Gladstone Financial Corp (NASDAQ:PGC) is a huge mover today! About 57,884 shares traded. Peapack-Gladstone Financial Corp (NASDAQ:PGC) has risen 63.29% since July 17, 2016 and is uptrending. It has outperformed by 46.59% the S&P500.The move comes after 5 months positive chart setup for the $586.87M company. It was reported on Jul, 17 by Barchart.com. We have $34.60 PT which if reached, will make NASDAQ:PGC worth $17.61M more.

Rexahn Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical firm engaged in the discovery, development and commercialization of treatments for cancer. The company has market cap of $70.97 million. The Company’s clinical-stage drug candidates in active development include Archexin, RX-3117 and Supinoxin . It currently has negative earnings. Archexin is a potent inhibitor of the protein kinase Akt-1, which focuses on cancer cell proliferation, survival, angiogenesis, metastasis and drug resistance.

Investors sentiment decreased to 1.96 in 2016 Q4. Its down 0.22, from 2.18 in 2016Q3. It fall, as 4 investors sold Peapack-Gladstone Financial Corp shares while 23 reduced holdings. 19 funds opened positions while 34 raised stakes. 11.06 million shares or 5.18% more from 10.51 million shares in 2016Q3 were reported. California Employees Retirement Sys reported 0% in Peapack-Gladstone Financial Corp (NASDAQ:PGC). Citigroup has 0% invested in Peapack-Gladstone Financial Corp (NASDAQ:PGC) for 16,722 shares. Matarin Cap Mngmt Ltd Liability Com has 0% invested in Peapack-Gladstone Financial Corp (NASDAQ:PGC). Cannell Peter B & Co Inc holds 7,472 shares or 0.01% of its portfolio. 216,170 are owned by Wellington Mngmt Gp Llp. Royal Retail Bank Of Canada reported 9,813 shares. Peapack Gladstone Financial Corp, New Jersey-based fund reported 687,861 shares. Patriot Financial Prtn Group L P stated it has 574,711 shares. Basswood Mngmt Limited Com holds 1.12M shares or 1.52% of its portfolio. Lsv Asset Management reported 51,800 shares or 0% of all its holdings. Deutsche Bancshares Ag stated it has 0% in Peapack-Gladstone Financial Corp (NASDAQ:PGC). Prudential Financial has invested 0% in Peapack-Gladstone Financial Corp (NASDAQ:PGC). Price Michael F invested 0.38% of its portfolio in Peapack-Gladstone Financial Corp (NASDAQ:PGC). Blackrock has 0% invested in Peapack-Gladstone Financial Corp (NASDAQ:PGC). Renaissance Technologies Ltd Liability Corp stated it has 0.01% of its portfolio in Peapack-Gladstone Financial Corp (NASDAQ:PGC).

Peapack-Gladstone Financial Corporation is a bank holding company. The company has market cap of $586.87 million. The Company’s principal subsidiary is Peapack-Gladstone Bank , which is a state chartered commercial bank. It has a 19.58 P/E ratio. The Firm operates through two divisions: Banking and Private Wealth Management Division.

Since February 27, 2017, it had 0 insider buys, and 1 sale for $73,558 activity. CONSI ANTHONY J also sold $73,558 worth of Peapack-Gladstone Financial Corp (NASDAQ:PGC) on Monday, February 27.

Anson Funds Management Lp holds 0.24% of its portfolio in Rexahn Pharmaceuticals, Inc. for 5.41 million shares. Sabby Management Llc owns 7.33 million shares or 0.06% of their US portfolio. Moreover, Benin Management Corp has 0.01% invested in the company for 113,000 shares. The New York-based Hudson Valley Investment Advisors Inc Adv has invested 0.01% in the stock. Northeast Financial Consultants Inc, a Connecticut-based fund reported 150,000 shares.

About 154,231 shares traded. Rexahn Pharmaceuticals, Inc. (RNN) has risen 54.48% since July 17, 2016 and is uptrending. It has outperformed by 37.78% the S&P500.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

>